Research Paper
Year: 2022 | Month: January | Volume: 9 | Issue: 1 | Pages: 45-50
DOI: https://doi.org/10.52403/ijrr.20220107
Treatment Motivation in Lung Tuberculosis Patients at Public Health Centres in Denpasar City during COVID-19 Pandemic
Jonathan Setiawan1, Ida Ayu Alit Widhiartini2, I Gusti Made Aman3
1Faculty of Medicine, Udayana University, Denpasar, Indonesia
2,3Department of Pharmacology, Faculty of Medicine, Udayana University, Denpasar, Indonesia
Corresponding Author: Ida Ayu Alit Widhiartini (widhiartini@unud.ac.id)
ABSTRACT
Treatment motivation among patients were heavily influenced by duration of therapy and existing side effects. TB supervisors motivated patients in their therapy. Limited communication from TB supervisors due to COVID-19 pandemic risked lowering treatment motivation in TB patients. Objective: get a general description of treatment motivation in TB patients from PHC in Denpasar. Method: descriptive observational with cross-sectional design in March – August 2021 at five PHC in Denpasar area. This study was done online using questionnaire with Google Forms application. Motivation is grouped into low, moderate, and high based on scores from internal factors, external factors, confidence in treatment, and interpersonal help seeking. Results: 86% of patients (43 people) had high treatment motivation, 12% of patients (6 people) have moderate treatment motivation, and two percent of patients (1 people) had low treatment motivation. Summary: Most of TB patients had high treatment motivation (86%). Communication between TB supervisors and patients are highly advised to motivate patients and increase success rate of therapy.
Keywords: [Anti tuberculosis drugs, Lung tuberculosis, Treatment motivation].
[PDF Full Text]